We defended Dexcom in the District of Delaware where Abbott asserted a dozen patents targeting Dexcom’s G6 continuous glucose monitoring technology. The Keker team narrowed the case to four patents prior to trial, including by invalidating an Abbott patent at summary judgment, and excluded Abbott’s expert testimony regarding reasonable royalty damages. Following a two-week trial, the jury invalidated another Abbott patent and found two were not infringed. The Court also declined to let the jury consider damages on the remaining patent, cementing a defense victory for the Keker trial team.

We are defending Google against a five-patent case brought by Daedalus Prime in the Western District of Texas targeting alleged power-management functionalities in Google’s Tensor system-on-chip products and Axion processors.

In conjunction with the ACLU of Northern California and Centro Legal de la Raza, we filed a class action challenging ICE’s policy of re-detaining people it had previously released, without any legal basis for re-arresting them. The court provisionally certified a class and stayed ICE’s policy of re-arresting asylum seekers and others who had been lawfully released without any material change in circumstances. ICE later stated that the court’s decision rendered ICE “non-operational” in the Bay Area.